相关实验视频

Updated: Jun 18, 2025

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

PRF1作为皮肤黑色素瘤淋巴转移的预后基因

Yufu Lin¹, Jia Liu², Shaozhuang Chen³

¹Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China; Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, China.

Biochemical and biophysical research communications

|July 31, 2024

概括

两种预后基因,FCGR3B和PRF1,被确定为皮肤皮肤黑色素瘤 (SKCM) 淋巴结转移. 开发了一个预后风险模型,以改善SKCM诊断和治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

皮肤皮肤黑色素瘤 (SKCM) 是一种侵袭性癌症,其中淋巴结转移是预后的关键指标.
鉴定预后基因对于改善SKCM患者的治疗结果至关重要.

研究的目的:

评估SKCM中淋巴结转移的预后意义.
确定新的预后基因,并构建SKCM的预测风险模型.
探索已识别的基因,免疫细胞透和临床结果之间的关系.

主要方法:

卡普兰-梅尔生存分析是在SEER和TCGA-SKCM数据集上进行的.
预后基因被确定,并构建了一个风险模型.
在体外和体内实验验证实了这些发现,包括CCK8,流式细胞计量,跨井测定和动物研究.

主要成果:

淋巴结转移与SKCM患者的预后较差有关.
确定FCGR3B和PRF1是显著的预后基因.
PRF1与CD8T细胞呈正相关性,与M2巨细胞呈负相关性,验证证实了这些关联.

结论:

FCGR3B和PRF1被确定为SKCM的关键预后基因.
开发了一种新的SKCM预后风险模型.
这些发现为SKCM的诊断和治疗提供了新的途径.

关键词:

免疫细胞是免疫细胞.亲属性皮肤黑色素瘤淋巴结转移是淋巴结的转移.预后基因是指预后基因的基因.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...